Back to results
CompletedPhase 2

Study Evaluating SRA-333 in Mild to Moderate Alzheimer's Disease (AD)

NCT00151333

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Phoenix, Arizona, United States

+2 additional locations

View on ClinicalTrials.gov
Study Evaluating SRA-333 in Mild to Moderate Alzheimer's Disease (AD) — TrialFind